R □ YALTY PHARMA Royalty Pharma plc MorphoSys Transaction Advancing innovation with complete funding solutions June 2, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contain all of the information you may desire. Sta ...

ROYALTY PHARMA UBS Global Healthcare Conference Terrance Coyne, EVP, Chief Financial Officer Marshall Urist, EVP, Co-Head of Research & Investments May 24, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contain all o ...

ROYALTY PHARMA 7th Annual Truist Securities 2021 Life Sciences Summit Terrance Coyne, EVP, Chief Financial Officer Christopher Hite, EVP, Vice Chairman Jim Reddoch, EVP, Co-Head Research & Investments and Chief Scientific Officer May 20, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. Th ...

ROYALTY PHARMA Bank of America 2021 Healthcare Conference Terrance Coyne, EVP, Chief Financial Officer Marshall Urist, EVP, Co-Head Research & Investments May 12, 2021 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contai ...

PRE-QUARTERLY RESULTS COMMUNICATION NEW YORK, NY, April 14, 2021 - Royalty Pharma plc (Nasdaq: RPRX) intends to announce its financial results for the first quarter of 2021 on May 11, 2021. An invitation for the results webcast will follow shortly. To assist in the financial modeling of its first quarter 2021 results, the company has compiled the following items. Non-GAAP Financial Measures Royalty Pharma focuses on certain non-GAAP financial measures to manage its business. These measures, which are presen ...

Royalty Pharma plc (NASDAQ:RPRX) Q1 2021 Earnings Conference Call May 11, 2021 8:00 AM ET Company Participants George Grofik - Senior Vice President and Head, Investor Relations and Communications Pablo Legorreta - Founder and Chief Executive Officer Marshall Urist - Executive Vice President and Co-Head, Research and Investments Jim Reddoch - Executive Vice President and Co-Head, Research and Investments & Chief Scientific Officer Terry Coyne - Executive Vice President and Chief Financial Officer Chris Hite ...

Royalty Pharma plc (NASDAQ:RPRX) Q4 2020 Earnings Conference Call February 17, 2021 8:00 AM ET Company Participants George Grofik - Senior Vice President, Head of Investor Relations and Communications Pablo Legorreta - Founder and Chief Executive Officer Jim Reddoch - Executive Vice President and Co-Head of Research and Investments Marshall Urist - Executive Vice President and Co-Head of Research and Investments Terry Coyne - Executive Vice President and Chief Financial Officer Chris Hite - Vice Chairman Co ...

Royalty Pharma plc (NASDAQ:RPRX) Q3 2020 Results Conference Call November 11, 2020 8:00 AM ET Company Participants George Grofik - SVP, Head, IR and Communications Pablo Legorreta - Founder and CEO Jim Reddoch - EVP and Head of Research & Investments Terry Coyne - EVP and CFO Chris Hite - Vice Chairman Marshall Urist - SVP, Research and Investments Conference Call Participants Geoff Meacham - Bank of America Steve Scala - Cowen David Risinger - Morgan Stanley Chris Schott - JP Morgan Greg Gilbert - Truist N ...

ROYALTY PHARMA ROYALTY PHARMA Royalty Pharma plc Q3 2020 Financial Results November 11, 2020 2 Forward Looking Statements & Non-GAAP Financial Information This presentation has been prepared by Royalty Pharma plc (the "Company"), is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are ma ...

Royalty Pharma plc (NASDAQ:RPRX) Q2 2020 Earnings Conference Call August 12, 2020 8:00 AM ET Company Participants George Grofik - Senior Vice President, Head of Investor Relations & Communications Pablo Legorreta - Founder & Chief Executive Officer Marshall Urist - Senior Vice President, Research & Investments Terry Coyne - Executive Vice President, Chief Financial Officer Conference Call Participants Geoff Meacham - Bank of America Chris Schott - JPMorgan Steve Scala - Cowen Gregg Gilbert - Truist David Ri ...